Pharmaceutical Industry Articles & Reports - Page 21

Examine how the EU Digital Omnibus impacts pharma AI and medical device compliance. Review AI Act timeline extensions, MDR integration, and GDPR data updates.

Explore a 90-day diagnostic framework for assessing AI readiness in pharma. Learn how to evaluate data governance, regulatory compliance, and integration.

Analyze AI governance in pharmacovigilance signal detection. Review CIOMS XIV and TransCelerate frameworks for risk-based oversight in drug safety monitoring.

Explore the agentic AI decision framework for the pharmaceutical industry. Learn how to assess build, buy, and partner models for clinical and R&D workflows.

Examine how agentic AI and systems like Microsoft Copilot support corporate PowerPoint workflows in 2026 by automating presentation creation and editing.

Examine the FDA and EMA Good AI Practice guidelines. This comprehensive implementation guide details the 10 regulatory principles for AI in drug development.

An in-depth comparison of leading pharma MES software: PAS-X, Tulip, MasterControl, and PharmaSuite. Analyze EBR, 21 CFR 11 compliance, and Pharma 4.0.

Explore the architecture and market dynamics of pharmacy management SaaS platforms. Learn about cloud hosting, EHR interoperability, and 2026 growth trends.

Analyze the scientific research capabilities of GPT-5.4 and Claude 4.6. Review how million-token context windows and autonomous tool-use aid data analysis.

Explore Ironclad AI capabilities in contract lifecycle management. This deep dive explains agentic architecture, AI Assist, and generative legal tech tools.

Guide to deploying AI in pharmacovigilance under the CIOMS XIV framework. Review core principles for risk-based oversight, model validation, and governance.

Understand the architecture of GxP-compliant data pipelines for pharma AI. This report analyzes data engineering frameworks using Databricks and Snowflake.

An in-depth comparative analysis of Peer AI and Weave Bio. Examine how these regulatory AI tools utilize LLMs to automate biopharma submission documents.

An analysis of EU AI Act high-risk compliance for pharmaceutical and medical device AI. Covers MDR/IVDR integration, data governance, and 2026 deadlines.

Examine HCP Master Data Management in pharma. Review data validation rules, identity verification, and Sunshine Act compliance for aggregate spend reporting.

Review the proposed changes in the IEC 62304 Edition 2 draft for medical device and health software: two process rigor levels, expanded scope, AI guidance and the expected timeline.

Examine the systemic causes of enterprise AI rollout failures. This report analyzes how poor data readiness, flawed integration, and overhype impact AI ROI.

Examine frameworks for calculating AI ROI in the pharmaceutical sector. Analyze quantitative metrics and payback periods for PV, regulatory, and manufacturing.

Analyze enterprise AI admin dashboards and usage controls for ChatGPT and Claude. This guide covers security, compliance, RBAC, and analytics features.

Analyze GLP-1 drug manufacturing dynamics, detailing global capacity expansions, CDMO production strategies, and peptide synthesis tech transfer processes.

Examine how boutique life sciences consulting firms guide pharmaceutical companies through AI adoption, digital health integration, and regulatory compliance.

Analyze CRO data integration patterns in clinical trials. Learn how sponsors use clinical data lakehouses, APIs, and AI for real-time data independence.

An analysis of Moderna's enterprise AI adoption strategy. Learn how the company achieved 100% generative AI usage through OpenAI tools and change management.

Examine how LLMs like ChatGPT fail in pharma and biotech. Review documented cases of fabricated clinical trials, wrong MOA descriptions, and fake citations.